HCG was used in the treatment of obesity disorders by a British Doctor and PHD, A.T.W. Simeons of the renown Salvator Mundi International Hospital in Rome Italy over a 16 year period commencing in the mid 1950’s. Dr. Simeons concluded that HCG (“Human Chorionic Gonadotrophic” Hormone) when used for weight reduction and concurrent with a regimented protein diet, not only resulted in significant weight loss from targeted areas where fat deposits were likely to collect, but also improved the lipolytic functions of the body when co-utilized with dietary protein sources. Dr. Simeons hypothesized that HCG, which is produced in the female body in large quantities at the time of pregnancy commencing from the 8th week forward and in quanitities ranging anywhere from 5000 mIU/ml to 288,000 mIU/ml, had a significant role in not only producing a healthy placenta for the fetus to survive, but also had a role in metabolizing fats from the mother’s subcutaneous fat stores as an additional ford source for the fetus.
Dr. Simeons theorized that by giving daily injections of small amounts of HCG concurrent with a high protein diet, that the HCG would mobilize the fat into the blood stream where protein and various enzymes could exercise their lipolytic functions (lipolytic means to break down fats usually for the consumption of energy). Dr. Simeons’ clinic had a 97% success ratio.